Viral infection: A potent barrier to transplantation tolerance

Clinical and Developmental Immunology

Volumn 2008, Issue , 2008, Pages

  Miller, David M ^a   Thornley, Thomas B ^a   Greiner, Dale L ^a   Rossini, Aldo A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; BYSTANDER EFFECT; CANCER RISK; CELL ACTIVATION; CLINICAL EFFECTIVENESS; GRAFT SURVIVAL; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INNATE IMMUNITY; NONHUMAN; ORGAN TRANSPLANTATION; PATIENT SAFETY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TRANSPLANTATION TOLERANCE; VIRUS INFECTION; ANIMAL; GRAFT REJECTION; HISTOCOMPATIBILITY; IMMUNOLOGY; METHODOLOGY; VIROLOGY;

ANIMALS; GRAFT REJECTION; HUMANS; IMMUNITY, INNATE; IMMUNOSUPPRESSION; SIGNAL TRANSDUCTION; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE; VIRUS DISEASES;

EID: 53149144296     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2008/742810     Document Type: Review

References (130)

1. Merrill J. P., Murray J. E., Harrison J. H., Guild W. R., Successful homotransplantation of the human kidney between identical twins The Journal of the American Medical Association 1956 160 4 277 282
2. Merrill J. P., Murray J. E., Harrison J. H., Guild W. R., Landmark article Jan 28, 1956: successful homotransplantation of the human kidney between identical twins. By John P. Merrill, Joseph E. Murray, J. Hartwell Harrison, and Warren R. Guild The Journal of the American Medical Association 1984 251 19 2566 2571
3. Merrill J. P., Transplantation immunology 1957-1975 Annales d'Immunologie 1978 129 2-3 347 352
4. Habwe V. Q., Posttransplantation quality of life: more than graft function American Journal of Kidney Diseases 2006 47 4, supplement 2 S98 S110
5. Cantarovich D., Vistoli F., Soulillou J.-P., Immunosuppression minimization in kidney transplantation Frontiers in Bioscience 2008 13 4 1413 1432
6. Ferry C., Socié G., Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned? Experimental Hematology 2003 31 12 1182 1186
7. Soulillou J., Giral M., Controlling the incidence of infection and malignancy by modifying immunosuppression Transplantation 2001 72 supplement 12 S89 S93
8. Laederach-Hofmann K., Bunzel B., Noncompliance in organ transplant recipients: a literature review General Hospital Psychiatry 2000 22 6 412 424
9. Paul L. C., Immunobiology of chronic renal transplant rejection Blood Purification 1995 13 3-4 206 218
10. Kreis H. A., Ponticelli C., Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors Transplantation 2001 71 supplement 11 SS5 SS9
11. Kamoun M., Mechanisms of chronic allograft dysfunction Therapeutic Drug Monitoring 2006 28 1 14 18
12. Rossini A. A., Greiner D. L., Mordes J. P., Induction of immunologic tolerance for transplantation Physiological Reviews 1999 79 1 99 141
13. Billingham R. E., Brent L., Medawar P. B., "Actively acquired tolerance" of foreign cells Nature 1953 172 4379 603 606
14. Owen R. D., Immunogenetic consequences of vascular anastomoses between bovine twins Science 1945 102 2651 400 401
15. Burnet F., Fenner F., The Production of Antibodies 1949 Melbourne, Australia MacMillan
16. Main J. M., Prehn R. T., Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow Journal of the National Cancer Institute 1955 15 4 1023 1029
17. Wekerle T., Kurtz J., Ito H., Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment Nature Medicine 2000 6 4 464 469
18. Seung E., Mordes J. P., Rossini A. A., Greiner D. L., Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning Journal of Clinical Investigation 2003 112 5 795 808
19. Durham M. M., Bingaman A. W., Adams A. B., Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning The Journal of Immunology 2000 165 1 1 4
20. Sharabi Y., Sachs D. H., Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen The Journal of Experimental Medicine 1989 169 2 493 502
21. Scandling J. D., Busque S., Dejbakhsh-Jones S., Tolerance and chimerism after renal and hematopoietic-cell transplantation The New England Journal of Medicine 2008 358 4 362 368
22. Kawai T., Cosimi A. B., Spitzer T. R., HLA-mismatched renal transplantation without maintenance immunosuppression The New England Journal of Medicine 2008 358 4 353 361
23. Larsen C. P., Knechtle S. J., Adams A., Pearson T., Kirk A. D., A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression American Journal of Transplantation 2006 6 5, part 1 876 883
24. Mescher M. F., Curtsinger J. M., Agarwal P., Signals required for programming effector and memory development by CD8+ T cells Immunological Reviews 2006 211 1 81 92
25. Snanoudj R., de Préneuf H., Créput C., Costimulation blockade and its possible future use in clinical transplantation Transplant International 2006 19 9 693 704
26. Greenwald R. J., Freeman G. J., Sharpe A. H., The B7 family revisited Annual Review of Immunology 2005 23 515 548
27. Schwartz R. H., T cell anergy Annual Review of Immunology 2003 21 305 334
28. Curtsinger J. M., Gerner M. Y., Lins D. C., Mescher M. F., Signal 3 availability limits the CD8 T cell response to a solid tumor The Journal of Immunology 2007 178 11 6752 6760
29. Curtsinger J. M., Lins D. C., Mescher M. F., Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function The Journal of Experimental Medicine 2003 197 9 1141 1151
30. Ohashi P. S., Oehen S., Buerki K., Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice Cell 1991 65 2 305 317
31. Oldstone M. B. A., Nerenberg M., Southern P., Price J., Lewicki H., Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response Cell 1991 65 2 319 331
32. Larsen C. P., Pearson T. C., The CD40 pathway in allograft rejection, acceptance, and tolerance Current Opinion in Immunology 1997 9 5 641 647
33. Foy T. M., Aruffo A., Bajorath J., Buhlmann J. E., Noelle R. J., Immune regulation by CD40 and its ligand GP39 Annual Review of Immunology 1996 14 591 617
34. Parker D. C., Greiner D. L., Phillips N. E., Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand Proceedings of the National Academy of Sciences of the United States of America 1995 92 21 9560 9564
35. Larsen C. P., Alexander D. Z., Hollenbaugh D., CD40-gp39 interactions play a critical role during allograft rejection: suppression of allograft rejection by blockade of the CD40-gp39 pathway Transplantation 1996 61 1 4 9
36. Elster E. A., Xu H., Tadaki D. K., Treatment with the humanized CD154-specific monoclonal antibody, hu5c8, prevents acute rejection of primary skin allografts in nonhuman primates Transplantation 2001 72 9 1473 1478
37. Kenyon N. S., Fernandez L. A., Lehmann R., Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154 Diabetes 1999 48 7 1473 1481
38. Kenyon N. S., Chatzipetrou M., Masetti M., Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154 Proceedings of the National Academy of Sciences of the United States of America 1999 96 14 8132 8137
39. Preston E. H., Xu H., Dhanireddy K. K., IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates American Journal of Transplantation 2005 5 5 1032 1041
40. Markees T. G., Phillips N. E., Noelle R. J., Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand Transplantation 1997 64 2 329 335
41. Iwakoshi N. N., Markees T. G., Turgeon N., Skin allograft maintenance in a new synchimeric model system of tolerance The Journal of Immunology 2001 167 11 6623 6630
42. Iwakoshi N. N., Mordes J. P., Markees T. G., Phillips N. E., Rossini A. A., Greiner D. L., Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner The Journal of Immunology 2000 164 1 512 521
43. Lenschow D. J., Zeng Y., Thistlethwaite J. R., Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg Science 1992 257 5071 789 792
44. Lin H., Bolling S. F., Linsley P. S., Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion The Journal of Experimental Medicine 1993 178 5 1801 1806
45. Larsen C. P., Elwood E. T., Alexander D. Z., Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways Nature 1996 381 6581 434 438
46. Yamazaki M., Pearson T., Brehm M. A., Different mechanisms control peripheral and central tolerance in hematopoietic chimeric mice American Journal of Transplantation 2007 7 7 1710 1721
47. Durie F. H., Aruffo A., Ledbetter J., Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease Journal of Clinical Investigation 1994 94 3 1333 1338
48. Takeuchi O., Akira S., Recognition of viruses by innate immunity Immunological Reviews 2007 220 1 214 224
49. Pascher A., Proesch S., Pratschke J., Rat cytomegalovirus infection interferes with anti-CD4 mAb-(RIB 5/2) mediated tolerance and induces chronic allograft damage American Journal of Transplantation 2006 6 9 2035 2045
50. Stapler D., Lee E. D., Selvaraj S. A., Expansion of effector memory TCR V β 4+ CD8+ T cells is associated with latent infection-mediated resistance to transplantation tolerance The Journal of Immunology 2008 180 5 3190 3200
51. Williams M. A., Tan J. T., Adams A. B., Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance The Journal of Immunology 2001 167 9 4987 4995
52. Williams M. A., Onami T. M., Adams A. B., Cutting edge: persistent viral infection prevents tolerance induction and escapes immune control following CD28/CD40 blockade-based regimen The Journal of Immunology 2002 169 10 5387 5391
53. Adams A. B., Williams M. A., Jones T. R., Heterologous immunity provides a potent barrier to transplantation tolerance Journal of Clinical Investigation 2003 111 12 1887 1895
54. Brehm M. A., Markees T. G., Daniels K. A., Greiner D. L., Rossini A. A., Welsh R. M., Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections The Journal of Immunology 2003 170 8 4077 4086
55. Forman D., Welsh R. M., Markees T. G., Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms The Journal of Immunology 2002 168 12 6047 6056
56. Turgeon N. A., Iwakoshi N. N., Phillips N. E., Viral infection abrogates CD8+ T-cell deletion induced by costimulation blockade Journal of Surgical Research 2000 93 1 63 69
57. Welsh R. M., Markees T. G., Woda B. A., Virus-induced abrogation of transplantation tolerance induced by donor- specific transfusion and anti-CD154 antibody Journal of Virology 2000 74 5 2210 2218
58. Obhrai J., Goldstein D. R., The role of toll-like receptors in solid organ transplantation Transplantation 2006 81 4 497 502
59. Kupiec-Weglinski J. W., Busuttil R. W., Ischemia and reperfusion injury in liver transplantation Transplantation Proceedings 2005 37 4 1653 1656
60. Romics L. Jr., Szabo G., Coffey J. C., Jiang H. W., Redmond H. P., The emerging role of toll-like receptor pathways in surgical diseases Archives of Surgery 2006 141 6 595 601
61. Fischer S. A., Graham M. B., Kuehnert M. J., Transmission of lymphocytic choriomeningitis virus by organ transplantation The New England Journal of Medicine 2006 354 21 2235 2249
62. Palacios G., Druce J., Du L., A new arenavirus in a cluster of fatal transplant-associated diseases The New England Journal of Medicine 2008 358 10 991 998
63. Turgeon N. A., Iwakoshi N. N., Meyers W. C., Virus infection abrogates cd8+ t cell deletion induced by donor-specific transfusion and anti-cd154 monoclonal antibody Current Surgery 2000 57 5 505 506
64. Thornley T. B., Brehm M. A., Markees T. G., TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts The Journal of Immunology 2006 176 3 1561 1570
65. Thornley T. B., Phillips N. E., Beaudette-Zlatanova B. C., Type 1 IFN mediates cross-talk between innate and adaptive immunity that abrogates transplantation tolerance The Journal of Immunology 2007 179 10 6620 6629
66. Chen L., Wang T., Zhou P., TLR engagement prevents transplantation tolerance American Journal of Transplantation 2006 6 10 2282 2291
67. Palmer S. M., Burch L. H., Davis R. D., The role of innate immunity in acute allograft rejection after lung transplantation American Journal of Respiratory and Critical Care Medicine 2003 168 6 628 632
68. Kim E. Y., Teh H.-S., TNF type 2 receptor (p75) lowers the threshold of T cell activation The Journal of Immunology 2001 167 12 6812 6820
69. Kim E. Y., Teh H.-S., Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28 The Journal of Immunology 2004 173 7 4500 4509
70. Curtsinger J. M., Valenzuela J. O., Agarwal P., Lins D., Mescher M. F., Cutting edge: type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation The Journal of Immunology 2005 174 8 4465 4469
71. Alexopoulou L., Holt A. C., Medzhitov R., Flavell R. A., Recognition of double-stranded RNA and activation of NF- κ B by Toll-like receptor 3 Nature 2001 413 6857 732 738
72. Yoneyama M., Kikuchi M., Natsukawa T., The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses Nature Immunology 2004 5 7 730 737
73. Kang D.-C., Gopalkrishnan R. V., Wu Q., Jankowsky E., Pyle A. M., Fisher P. B., mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties Proceedings of the National Academy of Sciences of the United States of America 2002 99 2 637 642
74. Saunders L. R., Barber G. N., The dsRNA binding protein family: critical roles, diverse cellular functions The FASEB Journal 2003 17 9 961 983
75. Gottenberg J.-E., Chiocchia G., Dendritic cells and interferon-mediated autoimmunity Biochimie 2007 89 6-7 856 871
76. Pichlmair A., Reis e Sousa C., Innate recognition of viruses Immunity 2007 27 3 370 383
77. Stetson D. B., Medzhitov R., Type I interferons in host defense Immunity 2006 25 3 373 381
78. Kurt-Jones E. A., Popova L., Kwinn L., Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus Nature Immunology 2000 1 5 398 401
79. Kawai T., Takahashi K., Sato S., IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction Nature Immunology 2005 6 10 981 988
80. Meylan E., Curran J., Hofmann K., Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus Nature 2005 437 7062 1167 1172
81. Seth R. B., Sun L., Ea C.-K., Chen Z. J., Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF- κ B and IRF3 Cell 2005 122 5 669 682
82. Xu L.-G., Wang Y.-Y., Han K.-J., Li L.-Y., Zhai Z., Shu H.-B., VISA is an adapter protein required for virus-triggered IFN- β signaling Molecular Cell 2005 19 6 727 740
83. Sun Q., Sun L., Liu H.-H., The specific and essential role of MAVS in antiviral innate immune responses Immunity 2006 24 5 633 642
84. Fitzgerald K. A., McWhirter S. M., Faia K. L., IKK ε and TBK1 are essential components of the IRF3 signaling pathway Nature Immunology 2003 4 491 496
85. Sharma S., TenOever B. R., Grandvaux N., Zhou G.-P., Lin R., Hiscott J., Triggering the interferon antiviral response through an IKK-related pathway Science 2003 300 5622 1148 1151
86. Kumar H., Kawai T., Kato H., Essential role of IPS-1 in innate immune responses against RNA viruses The Journal of Experimental Medicine 2006 203 7 1795 1803
87. Oganesyan G., Saha S. K., Guo B., Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response Nature 2006 439 7073 208 211
88. Häcker H., Redecke V., Blagoev B., Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 Nature 2006 439 7073 204 207
89. Honda K., Yanai H., Negishi H., IRF-7 is the master regulator of type-I interferon-dependent immune responses Nature 2005 434 7034 772 777
90. Honda K., Taniguchi T., IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors Nature Reviews Immunology 2006 6 9 644 658
91. Ishii K. J., Coban C., Kato H., A toll-like receptor-independent antiviral response induced by double-stranded B-form DNA Nature Immunology 2006 7 1 40 48
92. Stetson D. B., Medzhitov R., Recognition of cytosolic DNA activates an IRF3-dependent innate immune response Immunity 2006 24 1 93 103
93. Okabe Y., Kawane K., Akira S., Taniguchi T., Nagata S., Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation The Journal of Experimental Medicine 2005 202 10 1333 1339
94. Takaoka A., Wang Z., Choi M. K., DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response Nature 2007 448 7152 501 505
95. Heil F., Hemmi H., Hochrein H., Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8 Science 2004 303 5663 1526 1529
96. Diebold S. S., Kaisho T., Hemmi H., Akira S., Reis e Sousa C., Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA Science 2004 303 5663 1529 1531
97. Hemmi H., Takeuchi O., Kawai T., A Toll-like receptor recognizes bacterial DNA Nature 2000 408 6813 740 745
98. Iwasaki A., Medzhitov R., Toll-like receptor control of the adaptive immune responses Nature Immunology 2004 5 10 987 995
99. Reis e Sousa C., Toll-like receptors and dendritic cells: for whom the bug tolls Seminars in Immunology 2004 16 1 27 34
100. Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity Cell 2006 124 4 783 801
101. Oshiumi H., Matsumoto M., Funami K., Akazawa T., Seya T., TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon- β induction Nature Immunology 2003 4 2 161 167
102. Hemmi H., Kaisho T., Takeuchi O., Small-antiviral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway Nature Immunology 2002 3 2 196 200
103. Kawai T., Sato S., Ishii K. J., Interferon- α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6 Nature Immunology 2004 5 10 1061 1068
104. Uematsu S., Sato S., Yamamoto M., Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon- α induction The Journal of Experimental Medicine 2005 201 6 915 923
105. Hoshino K., Sugiyama T., Matsumoto M., I κ B kinase- α is critical for interferon- α production induced by Toll-like receptors 7 and 9 Nature 2006 440 7086 949 953
106. Shinohara M. L., Lu L., Bu J., Osteopontin expression is essential for interferon- α production by plasmacytoid dendritic cells Nature Immunology 2006 7 5 498 506
107. Wickham S., Carr D. J. J., Molecular mimicry versus bystander activation: herpetic stromal keratitis Autoimmunity 2004 37 5 393 397
108. Fujinami R. S., von Herrath M. G., Christen U., Whitton J. L., Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease Clinical Microbiology Reviews 2006 19 1 80 94
109. Lu L.-F., Lind E. F., Gondek D. C., Mast cells are essential intermediaries in regulatory T-cell tolerance Nature 2006 442 7106 997 1002
110. Selin L. K., Brehm M. A., Naumov Y. N., Memory of mice and men: CD 8+ T-cell cross-reactivity and heterologous immunity Immunological Reviews 2006 211 1 164 181
111. Lee B. O., Hartson L., Randall T. D., CD40-deficient, influenza-specific CD8 memory T cells develop and function normally in a CD40-sufficient environment The Journal of Experimental Medicine 2003 198 11 1759 1764
112. Luft T., Pang K. C., Thomas E., Type I IFNs enhance the terminal differentiation of dendritic cells The Journal of Immunology 1998 161 4 1947 1953
113. Theofilopoulos A. N., Baccala R., Beutler B., Kono D. H., Type I interferons (α / β) in immunity and autoimmunity Annual Review of Immunology 2005 23 307 336
114. Coccia E. M., Severa M., Giacomini E., Viral infection and toll-like receptor agonists induce a differential expression of type I and λ interferons in humans plasmacytoid and monocyte-derived dendritic cells European Journal of Immunology 2004 34 3 796 805
115. Markees T. G., Phillips N. E., Gordon E. J., Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD 4+ T cells, interferon-gamma, and CTLA4 Journal of Clinical Investigation 1998 101 11 2446 2455
116. Graca L., Honey K., Adams E., Cobbold S. P., Waldmann H., Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance The Journal of Immunology 2000 165 9 4783 4786
117. Banuelos S. J., Markees T. G., Phillips N. E., Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD 4+ cell subsets and different mechanisms Transplantation 2004 78 5 660 667
118. Goldstein D. R., Tesar B. M., Akira S., Lakkis F. G., Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection Journal of Clinical Investigation 2003 111 10 1571 1578
119. Walker W. E., Nasr I. W., Camirand G., Tesar B. M., Booth C. J., Goldstein D. R., Absence of innate MyD88 signaling promotes inducible allograft acceptance The Journal of Immunology 2006 177 8 5307 5316
120. Zhou S., Kurt-Jones E. A., Mandell L., MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection European Journal of Immunology 2005 35 3 822 830
121. Bettelli E., Carrier Y., Gao W., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 2006 441 7090 235 238
122. Pasare C., Medzhitov R., Toll pathway-dependent blockade of CD 4+ CD 25+ T cell-mediated suppression by dendritic cells Science 2003 299 5609 1033 1036
123. Welsh R. M., Selin L. K., No one is naive: the significance of heterologous T-cell immunity Nature Reviews Immunology 2002 2 6 417 426
124. Selin L. K., Cornberg M., Brehm M. A., CD8 memory T cells: cross-reactivity and heterologous immunity Seminars in Immunology 2004 16 5 335 347
125. Yang H., Welsh R. M., Induction of alloreactive cytotoxic T cells by acute virus infection of mice The Journal of Immunology 1986 136 4 1186 1193
126. Nahill S. R., Welsh R. M., High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response The Journal of Experimental Medicine 1993 177 2 317 327
127. Yang H., Welsh R. M., Induction of allospecific and virus-specific memory cytotoxic T cells during acute arenavirus infections Medical Microbiology and Immunology 1986 175 2-3 137 139
128. Yang H., Dundon P. L., Nahill S. R., Welsh R. M., Virus-induced polyclonal cytotoxic T lymphocyte stimulation The Journal of Immunology 1989 142 5 1710 1718
129. Kingsley C. I., Karim M., Bushell A. R., Wood K. J., CD 25+ CD 4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses The Journal of Immunology 2002 168 3 1080 1086
130. Brook M. O., Wood K. J., Jones N. D., The impact of memory T cells on rejection and the induction of tolerance Transplantation 2006 82 1 1 9